Ticker Symbol: ARAV
Aravive Inc
$3.75 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001513818
Company Profile
versartis, inc. (nasdaq: vsar) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. the company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. versartis’ mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. learn more at www.versartis.com.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: River Oaks Tower
Website: https://aravive.com/
CEO: Gail McIntyre
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $0.18
Change:
$0.04
(
31.75%)
Days Range: $0.16 - $0.24
Beta: 1.95
52wk. High: $2.46
52wk. Low: $0.11
Ytd. Change -54.20%
50 Day Moving Average: $0.14
200 Day Moving Average: $1.02
Shares Outstanding: 73562648
Valuation
Market Cap: 1.4B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A